CD70 and neoplasm: Because CAR-T-cell efficacy is determined not only by its cytolytic activity, but also by the capacity of antigen-specific proliferation upon tumor challenge, we performed repetitive co-culture assays, in which CD70 CAR-T cells were repeatedly challenged with CD70-positive cells and ACHN-CD70 KO cells.